Woodrow D Anderson insider trades

Open-market stock purchases and sales by Woodrow D Anderson, Chief Accounting Officer at Indivior Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 9, 2026.

Recent trades

DateStockTradeValue
Aug 27, 2026INDV Indivior Pharmaceuticals, IncBought$53.5K
Aug 5, 2026INDV Indivior Pharmaceuticals, IncBought$54.4K
Mar 3, 2026INDV Indivior Pharmaceuticals, IncSold (not open market)$265K
Mar 3, 2026INDV Indivior Pharmaceuticals, IncBought (not open market)—
Mar 3, 2026INDV Indivior Pharmaceuticals, IncBought (not open market)—
Mar 3, 2026INDV Indivior Pharmaceuticals, IncBought (not open market)—
Mar 3, 2026INDV Indivior Pharmaceuticals, IncSold (not open market)$85.8K
Feb 10, 2026INDV Indivior Pharmaceuticals, IncBought (not open market)—
Feb 9, 2026INDV Indivior Pharmaceuticals, IncBought (not open market)—

Companies traded

  • INDV Indivior Pharmaceuticals, Inc: 2 buys, last Aug 27, 2026

Get free alerts when Woodrow D Anderson files a new trade →